CytoDyn (CYDY) Short term Debt (2011 - 2025)

CytoDyn's Short term Debt history runs 10 years deep, the most recent figure standing at $27.2 million for Q4 2025.

• Quarterly Short term Debt fell 4.67% year-over-year to $27.2 million in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $27.2 million (down 4.67% YoY) and the FY2025 annual result came in at $27.2 million, down 8.7% from the prior year.
• Short term Debt was $27.2 million for Q4 2025 at CytoDyn, roughly flat from $27.2 million in the prior quarter.
• Across five years, Short term Debt topped out at $62.7 million in Q2 2021 and bottomed at $27.1 million in Q1 2025.
• A 5-year average of $35.2 million and a median of $33.8 million in 2023 frame the typical range for Short term Debt.
• Annual changes were most pronounced in 2021 — Short term Debt surged 830.27% — and 2022, when it plunged 42.24%.
• CytoDyn's Short term Debt stood at $43.9 million in 2021, then decreased by 15.96% to $36.9 million in 2022, then fell by 10.88% to $32.9 million in 2023, then dropped by 13.32% to $28.5 million in 2024, then slipped by 4.67% to $27.2 million in 2025.
• Business Quant data shows CYDY's Short term Debt at $27.2 million in Q4 2025, $27.2 million in Q3 2025, and $27.2 million in Q2 2025.